Sorry, you need to enable JavaScript to visit this website.

Main Research and Development Centers

Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S. and U.K.

Andover, Massachusetts Research Site front entrance
Andover, Massachusetts

A 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities

Cambridge, Massachusetts Research Site building
Cambridge, Massachusetts

Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world

Groton, Connecticut Research Site front Pfizer signage
Groton, Connecticut

Where nearly every one of our products are, in part, developed

 La-Jolla.webp
La Jolla, California

With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.

Pearl River, New York Research Site campus aerial view
Pearl River, New York

The primary location for our company’s global Vaccine Research and Development work

Sandwich, UK Research Site building front
Sandwich, UK

Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups

St. Louis, MO Research Site front entrance
St. Louis, MO

A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details

Related Articles

Science & Innovation

Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection

For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.

Elderly man speaking with healthcare professional thumbnail

Science & Innovation

As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever

At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.

Up close image of a cell, thumbnail

Real People

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

Nicole, IBD discussion panel thumbnail